Drug profile · INN
telotristat etiprate
XERMELO
telotristat etiprate (XERMELO) is a tryptophan 5-hydroxylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — telotristat etiprate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 5
- Programs
- 6
- Data quality
- 0.84
Quick answer
telotristat etiprate (XERMELO) is a tryptophan 5-hydroxylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Tryptophan 5-hydroxylase inhibitor
Primary target: Tryptophan 5-hydroxylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 8653094
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use
granted -
US 8193204
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use
granted -
US 7968559
Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
granted -
US 7709493
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
granted -
US 7553840
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
granted
Frequently asked questions
What is telotristat etiprate?
telotristat etiprate (XERMELO) is a tryptophan 5-hydroxylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for telotristat etiprate?
XERMELO is a marketed brand name for telotristat etiprate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of telotristat etiprate?
telotristat etiprate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.